PTJ
CRBU icon

Paul Tudor Jones’s Caribou Biosciences CRBU Stock Holding History

Paul Tudor Jones’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,073
Closed -$58.9K – 3089
2024
Q3 		$58.9K Buy
+30,073
New +$61.6K ﹤0.01% 2616
2024
Q2 		– Sell
-29,583
Closed -$152K – 2384
2024
Q1 		$152K Buy
+29,583
New +$182K ﹤0.01% 2070
2023
Q1 		– Sell
-29,997
Closed -$188K – 2496
2022
Q4 		$188K Buy
+29,997
New +$267K ﹤0.01% 2142
2022
Q3 		– Sell
-35,216
Closed -$191K – 2358
2022
Q2 		$191K Buy
35,216
+1,476
+4% +$11.3K 0.01% 1836
2022
Q1 		$310K Buy
33,740
+3,719
+12% +$39.2K 0.01% 1536
2021
Q4 		$453K Buy
+30,021
New +$584K 0.01% 1548

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Paul Tudor Jones's CRBU Position: Q4 2024 in Review

Paul Tudor Jones sold out of Caribou Biosciences (CRBU) in Q4 2024, closing a stake of 30,073 shares — an estimated $58.9K sold.

Paul Tudor Jones first reported a position in CRBU in Q4 2021 and held it in 6 quarters. The position peaked at $453K in Q4 2021. 133 funds tracked by Wall St. Rank hold CRBU as of Q4 2024.

  • Paul Tudor Jones reported no remaining Caribou Biosciences position as of Q4 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 30,073 Caribou Biosciences shares in Q4 2024, an estimated $58.9K.
  • Paul Tudor Jones first reported a position in Caribou Biosciences in Q4 2021 and held it in 6 quarters.
  • Paul Tudor Jones's Caribou Biosciences position peaked at $453K in Q4 2021.
  • 133 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2024.

Based on Tudor Investment Corp's 13F filing for Q4 2024, filed 14 Feb 2025.